Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 33 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

3%

1 trials in Phase 3/4

Results Transparency

33%

4 of 12 completed with results

Key Signals

4 with results100% success

Data Visualizations

Phase Distribution

20Total
Not Applicable (7)
Early P 1 (1)
P 2 (11)
P 3 (1)

Trial Status

Completed12
Recruiting9
Active Not Recruiting4
Not Yet Recruiting4
Unknown3
Withdrawn1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 12 completed trials

Clinical Trials (33)

Showing 20 of 20 trials
NCT07835165Not ApplicableNot Yet RecruitingPrimary

A Comparative Study Evaluating the Impact of Intensive Dietary Care on Weight Change and Biological Parameters in Patients Who Underwent Surgery for Craniopharyngioma During the First Postoperative Year

NCT02792582Phase 2Active Not RecruitingPrimary

A Phase II Trial of Intensity-Modulated Proton Therapy for Incompletely Resected Craniopharyngioma and Observation for Craniopharyngioma After Radical Resection

NCT07809178Not Yet Recruiting

China Treatment Trial for Tumor in Sellar Region With Unruptured Intracranial Aneurysm

NCT01419067Phase 2Active Not RecruitingPrimary

A Phase II Trial of Limited Surgery and Proton Therapy for Craniopharyngioma or Observation After Radical Resection

NCT07703605Not Yet Recruiting

AI-Assisted MRI Molecular Subtyping in Pediatric Brain Tumors

NCT07316101Not ApplicableRecruiting

Clinical Trial of an Anti-Fog Drainage Device for Endoscopic Endonasal Sellar Region Tumor Surgery

NCT03194906Phase 2Completed

Memantine for Prevention of Cognitive Late Effects in Pediatric Patients Receiving Cranial Radiation Therapy for Localized Brain Tumors

NCT00840047Phase 2Active Not Recruiting

Methionine PET/CT Studies In Patients With Cancer

NCT04087902Active Not Recruiting

Long-Term Longitudinal QoL in Patients Undergoing EEA

NCT05465174Phase 2Recruiting

Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults

NCT07301554Not Yet RecruitingPrimary

Food Preferences and Craniopharyngiomas

NCT07342686CompletedPrimary

Hypothalamic-Stratified Nursing Pathway for Pediatric Craniopharyngioma

NCT02162732Not ApplicableCompleted

Molecular-Guided Therapy for Childhood Cancer

NCT07177482Not ApplicableRecruitingPrimary

ImmunoPET Targeting Trophoblast Cell-surface Antigen 2 (Trop-2) in Craniopharyngioma Patients

NCT06299891Phase 2Recruiting

Efficacy and Safety of Phentermine/Topiramate in Youth With Hypothalamic Obesity

NCT06874426Recruiting

The Impact of Endoscopic Endonasal Skull Base Surgery on Olfaction

NCT06801756RecruitingPrimary

Craniopharyngioma and Pregnancies

NCT04648462Recruiting

Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology

NCT04158284RecruitingPrimary

Multicenter Registry for Patients With Childhood.Onset Craniopharyngioma, Xanthogranuloma, Cysts of Rathke's Pouch, Meningioma, Pituitary Adenoma, Arachnoid Cysts

NCT05525273Phase 2RecruitingPrimary

Treatment of BRAF ( B-Rapidly Accelerated Fibrosarcoma) Mutated Papillary Craniopharyngioma

Scroll to load more

Research Network

Activity Timeline